MicroRNA involvement in esophageal carcinogenesis

Stefan David, Stephen Meltzer

Research output: Contribution to journalArticle

Abstract

MicroRNAs (miRs) have recently emerged as a novel class of gene expression regulators. The number of studies documenting an altered miR expression pattern in cancer continues to expand rapidly. Critical information is continuously gained regarding how aberrantly expressed miRs contribute to carcinogenesis. Current studies provide evidence that analyses of miR expression patterns have potential clinical applications toward developing tumor biomarkers to identify the presence and dissemination of esophageal cancer, as well as to assess tumor chemosensitivity or radiosensitivity. The incidence of esophageal cancer is on the rise, and this disease continues to portend a poor prognosis. The current review addresses ways in which altered miR expression contributes to esophageal carcinogenesis, along with how recent discoveries may be applied clinically.

Original languageEnglish (US)
Pages (from-to)612-616
Number of pages5
JournalCurrent Opinion in Pharmacology
Volume11
Issue number6
DOIs
StatePublished - Dec 2011

Fingerprint

Esophageal Neoplasms
MicroRNAs
Carcinogenesis
Radiation Tolerance
Tumor Biomarkers
Neoplasms
Gene Expression
Incidence

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

MicroRNA involvement in esophageal carcinogenesis. / David, Stefan; Meltzer, Stephen.

In: Current Opinion in Pharmacology, Vol. 11, No. 6, 12.2011, p. 612-616.

Research output: Contribution to journalArticle

@article{e93d150025b94a1086305df90a8eea63,
title = "MicroRNA involvement in esophageal carcinogenesis",
abstract = "MicroRNAs (miRs) have recently emerged as a novel class of gene expression regulators. The number of studies documenting an altered miR expression pattern in cancer continues to expand rapidly. Critical information is continuously gained regarding how aberrantly expressed miRs contribute to carcinogenesis. Current studies provide evidence that analyses of miR expression patterns have potential clinical applications toward developing tumor biomarkers to identify the presence and dissemination of esophageal cancer, as well as to assess tumor chemosensitivity or radiosensitivity. The incidence of esophageal cancer is on the rise, and this disease continues to portend a poor prognosis. The current review addresses ways in which altered miR expression contributes to esophageal carcinogenesis, along with how recent discoveries may be applied clinically.",
author = "Stefan David and Stephen Meltzer",
year = "2011",
month = "12",
doi = "10.1016/j.coph.2011.09.006",
language = "English (US)",
volume = "11",
pages = "612--616",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - MicroRNA involvement in esophageal carcinogenesis

AU - David, Stefan

AU - Meltzer, Stephen

PY - 2011/12

Y1 - 2011/12

N2 - MicroRNAs (miRs) have recently emerged as a novel class of gene expression regulators. The number of studies documenting an altered miR expression pattern in cancer continues to expand rapidly. Critical information is continuously gained regarding how aberrantly expressed miRs contribute to carcinogenesis. Current studies provide evidence that analyses of miR expression patterns have potential clinical applications toward developing tumor biomarkers to identify the presence and dissemination of esophageal cancer, as well as to assess tumor chemosensitivity or radiosensitivity. The incidence of esophageal cancer is on the rise, and this disease continues to portend a poor prognosis. The current review addresses ways in which altered miR expression contributes to esophageal carcinogenesis, along with how recent discoveries may be applied clinically.

AB - MicroRNAs (miRs) have recently emerged as a novel class of gene expression regulators. The number of studies documenting an altered miR expression pattern in cancer continues to expand rapidly. Critical information is continuously gained regarding how aberrantly expressed miRs contribute to carcinogenesis. Current studies provide evidence that analyses of miR expression patterns have potential clinical applications toward developing tumor biomarkers to identify the presence and dissemination of esophageal cancer, as well as to assess tumor chemosensitivity or radiosensitivity. The incidence of esophageal cancer is on the rise, and this disease continues to portend a poor prognosis. The current review addresses ways in which altered miR expression contributes to esophageal carcinogenesis, along with how recent discoveries may be applied clinically.

UR - http://www.scopus.com/inward/record.url?scp=82255162676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82255162676&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2011.09.006

DO - 10.1016/j.coph.2011.09.006

M3 - Article

C2 - 21992930

AN - SCOPUS:82255162676

VL - 11

SP - 612

EP - 616

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

IS - 6

ER -